Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Symptom management in multiple sclerosis

R T Schapiro1

  • 1Fairview Multiple Sclerosis Center, Minneapolis, MN 55454.

Annals of Neurology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Managing symptoms of multiple sclerosis (MS) can significantly improve quality of life, even if the disease course cannot be altered. This review focuses on pharmacological approaches and newer therapies for MS symptom management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.

Current neurology and neuroscience reports·2002
Same author

Medications used in the treatment of multiple sclerosis.

Physical medicine and rehabilitation clinics of North America·1999
Same author

Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis.

Archives of physical medicine and rehabilitation·1998
Same author

Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis.

Archives of neurology·1997
Same author

Symptomatic therapy of multiple sclerosis.

Current opinion in neurology·1994
Same author

New advances in symptom management in multiple sclerosis.

Clinical neuroscience (New York, N.Y.)·1994
Same journal

AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.

Annals of neurology·2026
Same journal

Five Issues of Artificial Intelligence in Science: Sailing the Ship of Theseus.

Annals of neurology·2026
Same journal

Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

Annals of neurology·2026
Same journal

Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

Annals of neurology·2026
Same journal

Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

Annals of neurology·2026
Same journal

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Rehabilitation Medicine

Background:

  • Multiple sclerosis (MS) is a chronic disease with limited treatment options to alter its course.
  • Symptom management is crucial for improving the quality of life for individuals with MS.
  • MS symptoms are categorized into primary (demyelination-related), secondary (resulting from primary symptoms), and tertiary (psychosocial) issues.

Purpose of the Study:

  • To review standard and newer management solutions for multiple sclerosis symptoms.
  • To emphasize the pharmacological approach to symptom management in MS.
  • To highlight the integration of rehabilitation and medication for effective symptom alleviation.

Main Methods:

  • Review of existing literature on multiple sclerosis symptom management.
  • Focus on pharmacological therapies and emerging treatment strategies.

Related Experiment Videos

  • Consideration of the interplay between medication and rehabilitation.

    • Main Results:

    • Standard therapies exist for MS symptom management.
    • Newer management solutions offer potential for improved life-management plans.
    • Pharmacological interventions are emphasized for symptom control.
    • Rehabilitation and medication are integral to alleviating MS symptoms.

    Conclusions:

    • While the course of MS may be difficult to alter, effective symptom management significantly enhances patient well-being.
    • A comprehensive life-management plan for MS should integrate pharmacological treatments with rehabilitation strategies.
    • Further exploration of newer therapies is warranted to optimize care for individuals with MS.